Archives of Oral Biology
Volume 55, Issue 7 , Pages 530-534 , July 2010

Protocol on induction of TMJ articular disc degeneration in rats by utilization of botulinum toxin

,Accepted 22 March 2010.

References 

  1. Nunez SC, Garcez AS, Suzuki SS. Management of mouth opening in patients with temporomandibular disorders through low-level laser therapy and transcutaneous electrical neural stimulation. Photomed Laser Surg. 2006;24(1):45–49
  2. Cooper BC, Kleinberg I. Examination of a large patient population for the presence of symptoms and signs of temporomandibular disorders. Cranio. 2007;25(2):114–126
  3. Fischer L, Clemente T, Tambeli CH. The protective role of testosterone in the development of temporomandibular joint pain. J Pain. 2007;8(5):437–442
  4. Bhutada MK. Functions of the lateral pterygoide muscle. Ann R Australas Coll Dent Surg. 2004;17:68–69
  5. Holmlund A. Disc derangements of the temporomandibular joint. A tissue-based characterization and implications for surgical treatment. Int J Oral Maxillofac Surg. 2007;36:571–576
  6. Roda RP, Bagán JV, Fernández JMD, Bazán SH, Soriano YJ. Review of temporomandibular joint pathology. Part I: Classification, epidemiology and risk factors. Med Oral Patol Cir Bucal. 2007;12:E292–E298
  7. Tanaka E, Eijden TV. Biomechanical behavior of the temporomandibular joint disk. Crit Rev Oral Biol Med. 2003;14(2):138–150
  8. Fujita S, Hoshino K. Histochemical and immunohistochemical studies of the articular disk of the temporomandibular joint in rats. Acta Anat (Bassel). 1989;134(1):26–30
  9. Detamore MS, Athanasiou KA. Motivation, characterization, and strategy for tissue engineering the temporomandibular joint disk. Tissue Eng. 2003;9(6):1065–1087
  10. Axelsson S, Holmlund A, Hjerpe A. Glycosaminoglycans in normal and osteoarthrotic human temporomandibular joint disks. Acta Odontol Scand. 1992;50(2):113–119
  11. Paegle DI, Holmlund AB, Hjerpe A. Matrix glycosaminoglycans in the temporomandibular joint in patients with painful clicking and chronic closed lock. Int J Oral Maxillofac Surg. 2003;32:397–400
  12. Wong BJF, Pandhoh N, Truong MT, Diaz S, Chao K, Hou S, et al. Identification of condrocyte proliferation following laser irradiation, thermal injury, and mechanical trauma. Laser Surg Med. 2005;37:89–96
  13. Herzog W, Longino D, Clark A. The role of muscles in joint adaptation and degeneration. Langenbecks Arch Surg. 2003;233(5):305–315
  14. Okesson JP. Management of temporomandibular disorders and occlusion. 2nd ed.. St Louis: Mosby-Year Book Inc.; 1991;p. 117–164
  15. Nickel JC, Iwasaki LR, Beatty MW, Moss MA, Marx DB. Static and dynamic loading effects on temporomandibular joint disc tractional forces. J Dent Res. 2006;85(9):809–813
  16. Freund B, Schwartz M, Symington JM. Botulinum toxin: new treatment for temporomandibular disorders. Br J Oral Maxillofac Surg. 2000;38:466–471
  17. Schwartz M, Freund B. Treatment of temporomandibular disorders with botulinum toxin. Clin J Pain. 2002;18(6 Suppl):S198–203
  18. Guarda-Nardini L, Manfredini D, Salamone M, Salmaso L, Tonello S, Ferronato G. Efficacy of botulinum toxin in treating myofascial pain in bruxers: a controlled placebo pilot study. Cranio. 2008;26(2):126–135
  19. Ihde SK, Konstantinovic VS. The therapeutic use of botulinum toxin in cervical and maxillofacial conditions: an evidence-based review. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2007;104(2):E1–E11
  20. Kim JY, Kim ST, Cho SW, Jung HS, Park KT, Son HK. Growth effects of botulinum toxin type A injected into masseter muscle on a developing rat mandible. Oral Dis. 2008;14(7):626–632
  21. Bakke M, Moller E, Werdelin LM, Dalager T, Kitai N, Kreiborg S. Treatment of severe temporomandibular joint clicking with botulinum toxin in the lateral pterygoid muscle in two cases of anterior disc displacement. Oral Surg Med Oral Pathol Oral Radiol Endod. 2005;100(6):693–700
  22. Yoshida K, Iizuka T. Botulinum toxin treatment for upper airway collapse resulting from temporomandibular joint dislocation due to jaw-opening dystonia. Cranio. 2006;24(3):217–222
  23. Morbiato L, Carli L, Johnson EA, Montecucco C, Molgó J, Rossetto O. Neuromuscular paralysis and recovery in mice injected with botulinum neurotoxins A and C. Eur J Neurosci. 2007;25:2697–2704
  24. Minamoto VB, Hulst JB, Lim M, Peace WJ, Bremner SN, Ward SR, et al. Increased efficacy and decreased systemiceffects of botulinum toxin A injection after active or passive muscle manipulation. Dev Med Child Neurol. 2007;49:907–914
  25. Choi WH, Song CW, Kim YB, Ha CS, Yang GH, Woo HD, et al. Skeletal muscle atrophy induced by intramuscular repeated dose of botulinum toxin type A in rats. Drug Chem Toxicol. 2007;30(3):217–227
  26. Shen J, Ma J, Lee C, Smith BP, Smith TL, Tan KH, et al. How muscles recover from paresis and atrophy after intramuscular injection of botulinum toxin A: study in juvenile rats. J Orthopaed Res. 2006;24(5):1128–1135
  27. Heinegård D, Sommarin I. Proteoglycans: an overwiew. Method Enzymol. 1987;144:305–372
  28. Zingales B. Analysis of protein sodium dodecyl sulfate-polyacrylamide gel electrophoresis. Genes and antigens of parasites. Rio de Janeiro: Fiocruz; 1984;p. 357–363
  29. Weber K, Osborni M. The reliability of molecular weight determination by SDS-polyacrylamide gel electrophoresis. J Biol Chem. 1969;244(16):4406–4412
  30. Gomes L, Pimentel ER. Detection of small proteoglycan present in xiphoid cartilage regions submitted to different biochemical forces. Br J Med Biol Res. 1994;27(9):2117–2124

PII: S0003-9969(10)00080-4

doi: 10.1016/j.archoralbio.2010.03.018

Archives of Oral Biology
Volume 55, Issue 7 , Pages 530-534 , July 2010

Article Tools

* Image Usage & Resolution